Runhua Feng

Dec 22, 2023 | jnm.snmjournals.org | Ying Miao |Runhua Feng |Teng Yu |Rui Guo

fibroblast activation protein inhibitorPET/CTneoadjuvant chemotherapylocally advanced gastric cancerIn patients with locally advanced gastric cancer (LAGC) before radical surgery, neoadjuvant chemotherapy (NAC) is increasingly being applied because it may help control focal lesions, downstage tumors, increase R0 resection rates, and improve the disease-free and overall survival of patients (1–4). However, the role of preoperative NAC in LAGC remains controversial (5,6).